Immunology Frontier Research Center, Osaka University - Specially appointed researcher
Industry
Medical / Health Care / Pharmaceuticals
About
After medical school, I was working as a chest surgeon from 2001 to 2008. Throughout my career as a surgeon treating tumours and involved in lung transplantations, I was in a quandary over seemingly opposing immunological issues. In tumour immunotherapy it was implausible to activate tumour-specific immune responses, and conversely, in transplantation it was unfeasible to suppress allograft specific immune response.
By studying the function and generation of regulatory T cells, it may be possible to establish a method for controlling antigen specific immune responses by inducing or blocking activities of regulatory T cells and improving the prognosis of advanced cancer and transplantatio...
We¡¯ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
